Utilisation and perceptions towards smart device visual acuity assessment in Australia: a mixed methods approach by Keel, S et al.
1Keel S, et al. BMJ Open 2019;9:e024266. doi:10.1136/bmjopen-2018-024266
Open access 
Utilisation and perceptions towards 
smart device visual acuity assessment in 
Australia: a mixed methods approach
Stuart Keel,1 Jane Scheetz,1 Edith Holloway,1 Xiaotong Han,2 William Yan,1 
Andreas Mueller,1 Mingguang He2,3
To cite: Keel S, Scheetz J, 
Holloway E, et al.  Utilisation 
and perceptions towards 
smart device visual acuity 
assessment in Australia: a mixed 
methods approach. BMJ Open 
2019;9:e024266. doi:10.1136/
bmjopen-2018-024266
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
024266). 
Received 18 May 2018
Revised 4 October 2018
Accepted 20 November 2018
1Centre for Eye Research 
Australia, University of 
Melbourne, Melbourne, Australia
2State Key Laboratory of 
Ophthalmology, Zhongshan 
Ophthalmic Center, Sun Yat-Sen 
University, Guangzhou, China
3Ophthalmology, Department 
of Surgery, University of 
Melbourne, Melbourne, Vic, 
Australia
Correspondence to
Professor Mingguang He;  
 mingguang_ he@ yahoo. com
Research
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Objectives To investigate mobile health product use in 
Australia and societal and clinician perceptions towards 
smartphone based visual acuity (VA) assessment tools.
Design Quantitative analysis of a cross-sectional survey 
delivered to the general public and thematic analysis of 
in-depth interviews of eye health clinicians.
setting Online survey within Australia and face-to-face 
in-depth interviews of clinicians.
Participants 1016 adults were recruited via Survey 
Monkey Audience, social media (Facebook and Twitter), 
Rotary Australia and Lions Clubs Australia. Six clinicians 
were recruited from private and public settings in 
Melbourne, Australia.
Primary and secondary outcome measures The study 
assessed socio-demographic characteristics, history of 
mobile health product use and perceived advantages and 
potential drawbacks of smartphone based VA assessment 
tools.
results A total of 14.4% of the study population had 
previously used a mobile-based health product. After 
adjusting for covariates, younger age (p=0.001), male 
gender (p=0.01) and higher income (>$45 000) were 
associated with increased likelihood of having used a 
mobile health product (p=0.005). Seventy-two per cent of 
participants would use an automated smartphone based 
VA assessment tool, provided that the accuracy was on 
par to that of human assessors. Convenience (37.3%) 
and cost-savings (15.5%) were ranked as the greatest 
perceived advantages. While test accuracy (50.6%), a lack 
of personal contact with healthcare providers (18.3%) and 
data security (11.9%) were the greatest concerns. Themes 
to emerge from clinician qualitative data included the 
potential benefits for identifying refractive error in patients, 
as well as the ability to self-monitor vision. Concerns were 
raised over the potential misuse of self-testing vision apps 
and the inability to detect pathology.
Conclusion Our findings suggest that a substantial 
proportion of the Australian population do not use mobile 
health products. Furthermore, there remains notable 
concerns, including test accuracy and data privacy, with 
smartphone-based VA assessment tools by both clinicians 
and the public.
IntrODuCtIOn 
Visual acuity (VA) is the most commonly 
performed measure of visual function 
globally.1 Clinically, VA assessment is important 
to quantify changes in vision over time and is 
a good predictor of the presence of refractive 
error.2 Additionally, in research settings, VA 
is a critical measure to assess the efficacy of 
therapies in clinical trials and to quantify the 
burden of vision impairment and blindness 
in population-based studies.1 
Developed in the 1860s, the Snellen chart 
remains the most common method of VA 
assessment in clinical practice.3 While this 
chart offers an inexpensive means to measure 
VA, it has a number of flaws including a 
variable number of letters per line and 
non-geometric progression of letter size.4 5 
The retro-illuminated LogMAR acuity chart 
overcomes these limitations and is currently 
considered to be the gold standard in vision 
assessment. Despite this, the LogMAR chart 
has not been widely adopted for clinical use, 
strengths and limitations of this study
 ► This study, to the best of our knowledge, is the first 
to investigate the utilisation and perceptions of mo-
bile health products in both eye healthcare clinicians 
and a large and diverse sample of the Australian 
public.
 ► Given smart device-based vision testing apps offer 
substantial potential to improve accessibility of vi-
sion testing clinically and in patients’ homes, and 
their availability is becoming more prevalent, we 
explored the perceptions of two diverse groups to-
wards these tools.
 ► While our cross-sectional survey included a large 
representative sample of Australian adults, the sur-
vey responses relied on self-report and therefore we 
cannot discount the potential influences of self-re-
porting bias. Response rates were also unable to be 
ascertained which may cause uncertainty over the 
validity of the data.
 ► General practitioners were not included in the in-
depth interviews which may have added strength to 
the findings as they play an integral role in vision 
assessment in primary care settings.
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which is likely due to a longer testing speed required, 
larger chart size and cost.1
In recent years, there has been a rapid emergence 
of smart phone applications (apps) that enable VA 
assessment. Given the fact that there are an estimated 
2.6 billion smartphone subscriptions globally,6 these 
apps offer substantial potential to improve accessibility 
of VA testing, particularly in undeserved population 
and developing regions. However, to date, very few of 
these smartphone based VA assessment tools have been 
robustly validated7–9 and there remains limited data on 
acceptance and understanding of these technologies by 
both the public and clinicians, posing a significant barrier 
to their uptake within clinical, research and screening 
settings. In the present study, we sought to investigate the 
perception and attitudes of potential end-users (patients 
and clinicians) towards smartphone-based VA assessment 
tools and explore factors associated with these views.
MAterIAls AnD MethODs
This study employed a mixed methods approach to 
analyse societal and clinician acceptance and under-
standing of smartphone-based VA assessment tools. The 
study included two components: (1) a cross-sectional 
survey of the general public and (2) in-depth interviews 
with eye health clinicians. The design, sample and data 
analysis of each sub-study is described separately in the 
following sections.
Cross-sectional survey of the Australian public
Study design and sample
The majority of participants were recruited via Survey 
Monkey Audience, with a small proportion also recruited 
via social media (Facebook and Twitter), and the commu-
nity service groups of Rotary Australia and Lions Clubs 
Australia. The link to the survey was available for a 3-month 
period from July to September 2017 and all questions 
were presented in the same order for all participants. 
Survey Monkey Audience quota sampling capability was 
employed in an attempt to achieve a diverse demographic 
distribution. Fifty cents (AUD) was donated to a charity 
of the respondents’ choice for those who completed the 
survey via the Survey Monkey Audience platform. Once 
the respondents clicked on the survey link, they were 
screened to ensure they were 18 years or older and spoke 
English.
survey items
An online survey was developed by the qualitative 
research team at the Centre for Eye Research Australia 
to investigate previous utilisation of mobile health 
products and perceptions, advantages and potential 
drawbacks of smartphone based VA assessment tools 
(online supplementary table 1). Survey items were 
peer-reviewed and piloted on a small group of recipi-
ents prior to implementation. The questionnaire ascer-
tained the type of smart device/s owned by respondents, 
demographic details (age, gender, level of education 
and income level), ocular histories and previous utilisa-
tion of eye health services. The remainder of the survey 
questions related to:
 ► Previous utilisation of mobile health product/s.
 ► A scenario that explored the likelihood of using 
an automated, smartphone based VA assessment 
tool, provided it was as accurate as human assessors 
(pre-coded responses; ‘Yes’ or ‘No’).
 ► Perceived advantages of mobile phone-based vision 
testing (respondents ranked the most important 
factor based on pre-coded responses of; conveni-
ence, time-saving, cost-saving, improved access, more 
frequent testing).
 ► Greatest concerns about mobile phone-based vision 
testing (respondents ranked the most important 
factor based on pre-coded responses of; difficulty of 
use, accuracy, possibility of missed follow-up care, 
security of personal information, lack of personal 
contact with doctor).
 ► Who would need to endorse such a test (if anyone) 
for respondents to adopt it (pre-coded responses of; 
family/friend, health practitioner, would use without 
endorsement, would not use this technology)?
Data analysis
The de-identified data were downloaded directly from 
the Survey Monkey secure server and imported into the 
STATA V.14.0 (College Station, Texas, USA) for statis-
tical analysis. A p value of 0.05 was used for significance 
testing. Descriptive statistics were used to summarise 
demographic characteristics of the study population and 
χ2 tests were utilised to compare questionnaire responses. 
Logistic regression analysis was applied to assess the rela-
tionship between demographic variables and respon-
dent’s perceptions.
Clinician in-depth interviews
Study design and sample
Eye healthcare clinicians were prospectively recruited 
from private and public settings in Australia. Expressions 
of interest were circulated via e-mail through the Austra-
lian College of Optometry and Royal Victorian Eye and 
Ear Hospital via e-mail. Interested clinicians were purpo-
sively sampled to represent an even spread across three 
groups: gender, professional role (ophthalmologist and 
optometrist) and clinic type (public vs private). Face-to-
face interviews were conducted by an experienced qualita-
tive researcher (EH) during August 2017. Interviews were 
conducted in a private setting within the participants’ 
workplace or at the Centre for Eye Research Australia and 
each interview lasted 30–60 min. The in-depth interview 
included open-ended questions and probes, and its devel-
opment was informed by a thorough literature review 
and input from clinicians and the study team. Example 
interview questions are provided in online supplemen-
tary table 2.









pen: first published as 10.1136/bm





3Keel S, et al. BMJ Open 2019;9:e024266. doi:10.1136/bmjopen-2018-024266
Open access
Data analysis
The interviews were audio-recorded, transcribed 
verbatim, anonymised and imported into NVivo V.11 
to facilitate data management. A thematic analysis was 
conducted using an inductive ‘bottom-up’ approach, 
meaning that the themes identified were strongly linked 
to the data.10 Analysis commenced with researchers famil-
iarising themselves with the data and generating an initial 
coding framework, grounded in the data. Codes were 
gradually built into broader categories through compar-
ison across transcripts and higher-level recurring themes 
were developed. Emergent themes were discussed by two 
researchers (EH and AM) until a consensus was reached. 
Reliability was ensured through continuous discussion 
about the data with the research team and reflexivity was 
employed throughout the research. Written informed 
consent was obtained from all participants. The study was 
approved by the Royal Victorian Eye and Ear Hospital 
Human Research Ethics Committee and adhered to the 
tenets of the Declaration of Helsinki.
Patient and public involvement
No participants were involved in the development of the 
research question, outcome measures, nor the design, 
recruitment or implementation of the study. There are 
no plans to disseminate the results of the research to the 
survey participants or clinicians involved.
results
Cross-sectional survey of the Australian public
We analysed the cross-sectional survey responses from 1016 
participants from Australia. About 1002 (98.6%) provided 
complete demographic data and there was minimal attri-
tion (<2%) between all survey items. Key characteristics 
of the study population are provided in table 1. Partici-
pants were equally distributed across the four pre-defined 
age categories (range: 24.9% [45–59 years] to 25.2% 
[30–44 years]) and 50.1% (502/1002) were female. The 
current income level was >$45 000 in 49.4% (502/1016) 
of respondents and 45.3% (460/1016) had completed an 
undergraduate or post-graduate university degree. Sixty-
seven per cent (684/1016) of participants reported that 
they wore spectacle correction and 71.4% (725/1016) 
reported that they have their eyes examined at least every 
2 years.
A total of 14.4% (146/1016) of the study population 
had previously used a mobile-based health product. 
Multivariate logistic regression analysis was conducted to 
examining associations between demographic factors and 
previous use of a mobile health product (table 2, Model 
1). After adjusting for covariates (age, gender, education 
and income), male gender (Coefficient=0.51, p=0.01) and 
higher income (>$45 000) were associated with increased 
likelihood of having used a mobile health product (Coef-
ficient=0.73, p=0.005). Level of education was associated 
with acceptance, with participants who had completed a 
postgraduate degree being more likely to have used this 
technology than those with apprenticeship/Technical 
and Further Education (TAFE) qualifications (Coef-
ficient=0.86, p=0.005). In addition, respondents aged 
30–44 years were less likely to adopt mobile health prod-
ucts than those aged 18–29 years (Coefficient=−0.79, 
p=0.001).
Seventy-two per cent (731/1016) of participants 
responded that they would use an automated smartphone 
based VA assessment tool, provided that the accuracy was 
on par to that of human assessors. After multivariate 
adjustments, participants who had completed a postgrad-
uate degree were more likely to accept this technology 
than those with apprenticeship/TAFE qualifications 
(Coefficient=0.64, p=0.03) (table 2, Model 2). In addi-
tion, respondents aged 45–59 years were less likely to 
adopt smartphone based VA testing than those aged 
18–29 years (Coefficient=−0.52, p=0.02).
Convenience (37.3%, 379/1016) was ranked as the 
greatest perceived advantage of smartphone based VA 
testing, followed by cost-savings (15.5%, 157/1016) 
and ability to undertake more frequent testing (14.8%, 
150/1016). Overwhelmingly, test accuracy (50.6%, 
514/1016) was ranked as the greatest concern about 
mobile phone-based vision testing, this was followed by a 
lack of personal contact with healthcare providers (18.3%, 
186/1016) and concerns over security of personal infor-
mation (11.9%, 121/1016). To adopt this technology, the 
majority of respondents stated that it would need to be 
endorsed by a health practitioner (52.6%, 534/1016), 
with only approximately one quarter (25.5%, 259/1016) 
suggesting that they would consider using a smartphone 
based VA testing app without any recommendation.




  18–29 250 (24.95)
  30–44 252 (25.15)
  45–59 249 (24.85)
  60+ 251 (25.05)
Gender
  Female 502 (50.10)
  Male 500 (49.90)
Education
  Apprenticeship/TAFE 238 (23.43)
  Postgraduate (Masters, PhD) 128 (12.60)
  Secondary 318 (31.30)
  Tertiary (Undergraduate) 332 (32.68)
Income
  $45 000 or less 514 (50.59)
  $45 001–$79 999 297 (29.23)
  $80 000 or greater 205 (20.18)
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In-depth interviews
A total of 6 eye health clinicians participated in the qual-
itative study (ophthalmologists n=3; optometrists n=3). 
Clinician characteristics are summarised in table 3 and 
the key themes identified in the qualitative study are 
presented in the following sections. Detailed themes 
arising from the clinician interviews capturing the 
advantages and concerns of the test are presented in 
online supplementary tables 3 and 4.
Opportunities and advantages of an automated VA test
Clinicians perceived that the main advantage of an auto-
mated VA tool was in its potential to allow patients to 
self-monitor their VA between eye examinations (n=4, 
freq=11). They also commented that these tools may 
lead to an increased number of individuals presenting 
for an eye examination, thus improving early detection 
of eye disease (n=4; freq=7). Overall, 50% of participants 
(freq=9) perceived this tool to be useful for detecting 
uncorrected refractive error. All optometrists perceived 
the test to be useful for primary healthcare providers (both 
optometrists and general practitioners) when performing 
VA tests outside of the clinic (eg, home visits). One-third 
of clinicians (freq=9) reported that smart device-based 
vision testing could be a useful strategy for increasing 
public awareness of the importance of eye health and 
obtaining regular eye examinations.
Concerns and barriers
Clinicians reported concerns over the limited utility of 
smart device-based vision testing, given that VA can be 
normal in the presence of many eye pathologies, partic-
ularly in their early stages (n=6; freq=33). This theme 
was linked to concerns about a normal (or unchanged 
VA) test result deterring users from having a regular eye 
examination (n=4; freq=13). Other key concerns raised 
by clinicians related to the ability of these tools to reach 
at risk segments of the population, including individuals 
who do not engage in regular eye examinations (n=5; 
freq=6) and older adults or those with low vision who may 
be less likely to own or use a smartphone (n=3; freq=8).
Clinician recommendations
All clinicians expressed the importance of having a clear 
message that the automated test did not replace the need 
Table 2 Multivariate logistic regression analysis examining associations between demographic factors and previous use of a 
mobile health product (Model 1) and acceptance of smartphone-based visual acuity assessment (Model 2)
Model 1* Model 2†
Coefficient (95% CI) P valueCoefficient (95% CI) P value
Age
  18–29 (Ref) (Ref)
  30–44 −0.79 (−1.25 to −0.32) 0.001 −0.32 (−0.79 to −0.13) 0.16
  45–59 −1.23 (−1.75 to −0.71) 0.09 −0.52 (−0.97 to −0.08) 0.02
  60+ −2.13 (−2.83 to −1.42) 0.08 −1.55 (−1.97 to −1.13) 0.31
  Male gender 0.51 (0.12 to 0.89) 0.01 −0.08 (−0.37 to 0.21) 0.61
Education
  Apprenticeship/TAFE Ref Ref
  Postgraduate 0.86 (0.25 to 1.46) 0.005 0.64 (0.05 to 1.23) 0.03
  Secondary −0.19 (−0.77 to 0.38) 0.51 0.02 (−0.37 to 0.41) 0.92
  Tertiary 0.27 (−0.25 to 0.80) 0.31 0.007 (−0.39 to 0.40) 0.97
Income
  $45 000 or less (Ref) (Ref)
  $45 001–$79 999 0.53 (0.08 to 0.99) 0.02 0.20 (−0.14 to 0.55) 0.26
  $80 000 or greater 0.73 (0.22 to 1.23) 0.005 0.06 (−0.36 to 0.48) 0.79
*Model 1=previous use of a mobile health product.
†Model 2=acceptance of smartphone based VA assessment.






Mean age (SD) 51.0 (7.9) 35.7 (10.7)
Male, n (%) 3 (100) 1 (33.3)
Mean years working in 
professional role (SD)
22.0 (13.7) 13.83 (12.8)
Clinic type, n (%)
  Public 2 (66.6) 1 (33.3) 
  Private 1 (33.3) 2 (66.6) 
Setting, n (%)
  Urban 2 (66.6) 3 (100) 
  Rural 1 (33.3) 0 (0) 
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for a regular eye examination and that a change in VA 
should be followed up with an examination (freq=14). It 
was also suggested that the app should include a frequently 
asked questions section providing the user with an expla-
nation of their results in plain language (eg, If I have 
concerns about my vision, who should I call? What does 
my result mean?) and possible generic links to optometry 
or General Practitioner (GP) networks or to provide the 
user with a choice (n=4; freq=18) as to whether contact 
details for providers in their local area are provided.
Most clinicians suggested developing the vision test for 
an iPad (n=4; freq=9) would be beneficial, suggesting 
that older adults would be more likely to engage with this 
technology due to the larger screen size and healthcare 
providers (optometrists and general practitioners) could 
still utilise the vision test for home and rural visits when 
access to traditional testing instruments are limited. Other 
suggestions for the app features included incorporating 
culturally agnostic graphics, simple instructions (avoiding 
those which are multi-level), fun and engaging alerts to 
ensure the test is being performed correctly, no time limit 
to complete the test, the ability to repeat the test if an 
error was made and providing audio instructions ‘some of 
your subjects are not going to be very well-sighted …. so, I 
would recommend an audio option to describe the steps’.
DIsCussIOn
Smartphone-based applications are increasingly being 
used to support health behaviours, with an estimated 
500 million users of mobile health apps worldwide.11 
Currently, there are over 100 smart device-based vision 
testing apps available in the Google Play Store.1 This type 
of technology offers the potential for patients living in 
rural and remote areas who have limited access to health-
care providers, or those who require more frequent 
monitoring of their vision. While medical and academic 
communities have considerable influence on the devel-
opment and uptake of these technologies in the clin-
ical and research settings,1 12 it is the general public that 
drives the majority of uptake and usage patterns as most 
vision testing apps are freely downloadable and delivered 
independent of hands-on clinician support. Given the 
role that both clinicians and the public play in the devel-
opment and successful deployment of these apps, we 
conducted an online survey of the Australian population 
to investigate utilisation of mobile health products as well 
as public and clinician perceptions towards smart device-
based VA testing tools.
Our finding from the public survey that only 14% of 
participants had previously used a mobile-based health 
product is similar to that of a survey by Fox and Duggan13 
who reported that 19% of mobile phone users had a 
health app on their phone. However, it is notably lower 
than the reported 58% from a recent national survey from 
the USA.14 We can only speculate that variations in popu-
lation demographics between studies, and/or differences 
may exist in awareness or acceptance of mobile based 
health products between countries. In addition, differ-
ences in recruitment methods (telephone interview13 
and online survey14) may have contributed to the variable 
frequency of health app usage. The key concern of a lack 
of personal contact with healthcare providers that was 
identified in the present study, may provide evidence for 
lower levels of acceptance found. Older participants were 
less likely to adopt mobile based health products and this 
concern was raised by clinicians which is not surprising 
given the general perception of less comfort, efficacy and 
control over computers compared with their younger 
counterparts.15 However, given 85% of vision loss occurs 
in those aged 50 years or older,16 older adults would 
likely be one of the greatest beneficiaries of mobile vision 
apps. Interestingly, a recent report by Deloitte17 found 
that 82% of 55–64 years old and 78% of 65–75 years old 
own a smartphone, with the biggest growth being in the 
65–75-year-old bracket (up from 69% in 2016).17 Given 
this, future systems may benefit from making technology 
more user-friendly for all age groups. In the present study, 
clinicians suggested that ensuring the app is compatible 
with an iPad and providing instructions and results are 
clear with adjustable font size may be beneficial features 
to promote increased usage among older age groups.
Our findings suggest that the convenience of self-
testing, ability to monitor VA and cost-savings were 
identified by patients as the most important potential 
advantages of smart device-based VA tools. From a public 
health perspective, it is also obvious that, if accurate, these 
systems offer great potential as an inexpensive means to 
improve accessibility to VA screening, particularly low 
recourse areas. However, this research also identified a 
number of critical concerns relating to smartphone-based 
VA testing. In line with Krebs and Duncan,14 we report 
that the test accuracy was overwhelmingly the strongest 
concern among survey respondents. This is an encour-
aging finding given there could be significant conse-
quences of displaying unreliable VA data to patients. 
In addition, over half (53%) of the respondents stated 
that the mobile vision testing product would need to be 
endorsed by a health practitioner for them to adopt it. 
This level of societal caution towards smartphone-based 
VA tools appears to be well founded and mirrors recent 
commentary from the medical community1 as, to date, 
only a very few of the hundreds of apps available have 
been robustly validated for repeatability and reliability.7–9 
These findings highlight that Australian healthcare 
professionals may have a central role in informing and 
guiding patients to those apps that have undergone 
formal assessment. Another noteworthy concern identi-
fied by survey respondents involved data security (or lack 
thereof) of mobile health platforms. This finding is also 
consistent with that of Krebs and Duncan, reinforcing 
that the security of patient information should be at the 
forefront of the minds of software developers and these 
systems should be compliant with approved standards of 
data sharing. It should be noted, however, that our find-
ings in relation to potential cost savings is in contrast to 
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Krebs and Duncan, who reported that cost associated with 
downloading and using health apps was a strong concern 
for the public.
Clinicians raised concerns regarding the potential for 
misuse of smart device-based vision apps, suggesting that 
these tools may potentially deter some patients from 
having a regular eye examination, particularly if they 
believe their vision is stable. In line with this, the poten-
tial for a delayed diagnosis of eye disease was highlighted 
by all clinicians, given the preservation of VA is often seen 
in the early stages of many common blinding diseases, 
such as glaucoma and diabetic retinopathy.18 19 To avoid 
such issues patients must have a clear understanding 
of the importance of receiving regular, comprehensive 
eye examinations.20 The results the qualitative clinician 
study identified potential strategies to tackle these issues, 
including the use of clear messaging that the smart device-
based vision test does not replace the need for regular eye 
examinations, the provision of generic links to eyecare 
providers even, and a frequently asked questions section 
providing a plain language explanations of the results.
Typically, online surveys under-represent specific popu-
lation groups, including older people. A key strength of 
the current study includes the large and diverse sample of 
Australians across all age groups. A number of limitations 
must also be considered. First, selection bias towards those 
who use the internet more frequently may have impacted 
the positive perception towards the use of mobile health 
technology and smart devices. While it can be argued 
that those who don’t use the internet were under-repre-
sented, our survey sample was equally represented across 
all age groups and participants were engaged through 
community groups as well as via online avenues. Second, 
all survey responses relied on self-report and the majority 
of participants regularly participate in surveys managed 
by the survey company (Survey Monkey). Third, we were 
unable to ascertain non-response rates and therefore 
there is some uncertainty over the validity of the data. 
F, the inclusion of qualitative data from general practi-
tioners may have added strength to our findings given 
they are routinely involved in assessing vision within 
primary care settings.
The results from this study has implications for future 
research, including strategies to better educate and 
engage the public about smartphone-based VA tests. 
Additionally, insight from patients and clinicians will help 
guide the strategic development, usability and validity 
of future VA testing apps. Allowing users to customise 
settings to their own specific needs has been shown to 
enhance usefulness and levels of enjoyment with the tech-
nology.21–23 The results of qualitative studies such as this 
will improve the app developers understanding of poten-
tial barriers to user engagement and what features need 
to be incorporated prior to release.
In summary, while it appears that the younger popula-
tion in Australia are relatively accepting of smartphone 
based VA assessment tools and mobile health prod-
ucts in general, reservation remains among the older 
Australian population. While clinicians felt that vision 
testing apps would be useful for detecting refractive 
error and self-monitoring visual changes between exam-
inations, there remains notable concerns relating to test 
accuracy, usability and data privacy. We hope that this 
data can provide practical insight into strategies for the 
direction, development and validation of future vision 
testing apps.
Acknowledgements This work was supported by funding from Google Australia.
Contributors SK, JS, EH, WY and AM performed data collection and interpretation. 
EH, JS and XH conducted data analysis. SK, JS and EH wrote the main manuscript 
text and prepared figures. MH directed and supervised the project. All co-authors 
were actively involved in reviewing the manuscript.
Funding This work was supported in part by a Google Australia grant. Professor 
receives support from the University of Melbourne Research Accelerator Program 
and the CERA Foundation. The Centre for Eye Research Australia receives 
Operational Infrastructure Support from the Victorian State Government. The 
sponsor or funding organisation had no role in the design or conduct of this 
research. 
Competing interests None declared.
Patient consent for publication Obtained.
ethics approval Royal Victorian Eye and Ear Hospital Human Research Ethics 
Committee (HREC-17/1336). 
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The datasets generated during and/or analysed during 
the current study may be available from the corresponding author on reasonable 
request.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Brady CJ, Eghrari AO, Labrique AB. Smartphone-based visual 
acuity measurement for screening and clinical assessment. JAMA 
2015;314:2682–3.
 2. James B, Benjamin L. E-Book-ophthalmology: investigation and 
examination techniques: Elsevier Health Sciences, 2006.
 3. Hetherington R. The Snellen chart as a test of visual acuity. Psychol 
Forsch 1954;24:349–57.
 4. Elliott DB, Sheridan M. The use of accurate visual acuity 
measurements in clinical anti-cataract formulation trials. Ophthalmic 
Physiol Opt 1988;8:397–401.
 5. Ferris FL, Kassoff A, Bresnick GH, et al. New visual acuity charts for 
clinical research. Am J Ophthalmol 1982;94:91–6.
 6. Onnela JP, Rauch SL. Harnessing smartphone-based digital 
phenotyping to enhance behavioral and mental health. 
Neuropsychopharmacology 2016;41:1691–6.
 7. Bastawrous A, Rono HK, Livingstone IA, et al. Development and 
validation of a smartphone-based visual acuity test (peek acuity) for 
clinical practice and community-based fieldwork. JAMA Ophthalmol 
2015;133:930–7.
 8. Perera C, Chakrabarti R, Islam FM, et al. The eye phone study: 
reliability and accuracy of assessing snellen visual acuity using 
smartphone technology. Eye 2015;29:888–94.
 9. Tofigh S, Shortridge E, Elkeeb A, et al. Effectiveness of a smartphone 
application for testing near visual acuity. Eye 2015;29:1464–8.
 10. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res 
Psychol 2006;3:77–101.
 11. Kamerow D. Regulating medical apps: which ones and how much? 
BMJ 2013;347:f6009.
 12. Rodríguez-Vallejo M. Comment on 'The Eye Phone Study: reliability 
and accuracy of assessing Snellen visual acuity using smartphone 
technology'. Eye 2015;29:1627.









pen: first published as 10.1136/bm





7Keel S, et al. BMJ Open 2019;9:e024266. doi:10.1136/bmjopen-2018-024266
Open access
 13. Fox S, Duggan M. Mobile health 2012. Washington, DC: Pew Internet 
and American Life Project, 2013.
 14. Krebs P, Duncan DT. Health app use among US mobile phone 
owners: a national survey. JMIR Mhealth Uhealth 2015;3:e101.
 15. Czaja SJ, Charness N, Fisk AD, et al. Factors predicting the use of 
technology: findings from the Center for Research and Education 
on Aging and Technology Enhancement (CREATE). Psychol Aging 
2006;21:333–52.
 16. Organization WH. Universal eye health: a global action plan 2014-
2019. 2013.
 17. Deloitte. Mobile consumer survey 2017: the Australian cut. 2017.
 18. Lövestam-Adrian M, Agardh CD, Torffvit O, et al. Diabetic 
retinopathy, visual acuity, and medical risk indicators: a continuous 
10-year follow-up study in Type 1 diabetic patients under routine 
care. J Diabetes Complications 2001;15:287–94.
 19. Matsuura M, Hirasawa K, Murata H, et al. The relationship between 
visual acuity and the reproducibility of visual field measurements in 
glaucoma patients. Invest Ophthalmol Vis Sci 2015;56:5630–5.
 20. Glenn T, Monteith S. New measures of mental state and behavior 
based on data collected from sensors, smartphones, and the 
Internet. Curr Psychiatry Rep 2014;16:523.
 21. Chang W-L, Yuan S-T, Hsu CW. Creating the experience economy in 
e-commerce. Commun ACM 2010;53:122–7.
 22. Magrath V, McCormick H. Marketing design elements of mobile 
fashion retail apps. J of Fashion Marketing and Management: An 
International Journal 2013;17:115–34.
 23. Rose S, Clark M, Samouel P, et al. Online customer experience in 
e-retailing: an empirical model of antecedents and outcomes. Journal 
of Retailing 2012;88:308–22.









pen: first published as 10.1136/bm
jopen-2018-024266 on 23 M
arch 2019. D
ow
nloaded from
 
